|
Dr Francis Adu-Amankwaah
Stellenbosch University, South Africa
In-silico and in-vitro assessments of some fabaceae, rhamnaceae, apocynaceae, and anacardiaceae species against Mycobacterium tuberculosis H37Rv and triple-negative breast cancer cells
|
|
Dr Sasha Larsen Akins
Seattle Children's Research Institute, USA
Building reproducible and escalating preclinical models for mycobacteriophage efficacy testing
|
|
Dr Salem Almujri
King Khalid University, Saudi Arabia
Immunoinformatics-Driven Identification of Broadly Protective TB Vaccine Candidates
|
|
Dr Chiraz Atri
Institut Pasteur de Tunis, Tunisia
Implication of NR4A Transcription Factors during Leishmania-Macrophage Interactions
|
|
Prof Carina Carvalho dos Santos
Federal University of Bahia, Brazil
An immunoinformatics approach to identify potential epitopes for a tuberculosis vaccine
|
|
Dr Naomi Daniels
University of Otago, New Zealand
Immune Evasion Strategies of Beijing-Genotype Mycobacterium tuberculosis: Insights from Spatial Transcriptomic Analysis
|
|
Dr Huyen Dao Thi Ngoc
University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam
Knowledge and Practices Regarding Melioidosis Among Doctors in Southern Vietnam
|
|
Dr Taru Dutt
Colorado State University, USA
Lung-Resident B Cells in Tuberculosis: Unravelling Their Role in Local Immunity and Vaccine Development
|
|
Miss Beatrice Nassanga Francis
University of Oxford, UK
Developing bovine immune organoids for the screening of bovine TB vaccine candidates
|
|
Dr Camila Freitas
Federal University of Minas Gerais, Brazil
Immunization with Recombinant LiHyp1 Protein Plus Adjuvant Provides Protection Against Tegumentary Leishmaniasis in a murine model
|
|
Dr Tuhina Gupta
University of Georgia, USA
Assessing protection of novel nanoparticle-based vaccine against tuberculosis
|
|
Dr Mulualem Tadesse Jano
Jimma University, Ethiopia
High Rate of Indeterminate Rifampicin-Resistance in Pulmonary Tuberculosis Patients at Shenen Gibe Hospital, Jimma, Ethiopia: Implications for programmatic use of Xpert MTB/RIF Ultra Assay
|
|
Dr Shambhu Joshi
Mahabaudha Medical Center, Nepal
Quality of Life in Patients Affected by Rare Neglected Tropical Dermatological Diseases: Post Covid-19 Era
|
|
Mr Raphael Kamng'ona
MRC Unit The Gambia at LSHTM, The Gambia
Analysis of Immune cells and pathways in the development and outcome of post-TB lung disease
|
|
Dr Sabella Kiprono
Masinde Muliro University of Science and Technology, Kenya
Burden of Visceral Leishmaniasis and Associated Risk Factors Among Residents of Baringo County, Kenya
|
|
Dr Nastassja Kriel
Stellenbosch University, South Africa
Secretome characterization of viable but non-replicating enriched M. tuberculosis culture for TB vaccine candidate discovery
|
|
Dr Barbara Kronsteiner-Dobramysl
University of Oxford, UK
Features of T-cell dysfunction contributing to disease susceptibility in diabetes mellitus: implications for vaccine design
|
|
Miss Millicent Naa Koshie Lamptey
Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana
Monocyte transcriptome signatures of inflammation and enhance neutrophil recruitment characterize immunopathology in the blood of tuberculosis patients
|
|
Dr Clement Likhovole
Mount Kenya University, Kenya
Novel Diagnostic Molecular Technique based on Identical Multi Repeat Sequences on the Mycobacterium tuberculosis genome for the Detection of Tuberculosis
|
|
Mrs Erin McMaster
University of Oxford, UK
Investigating the effect of changing environmental conditions on the growth, virulence and genomic sequence of non-tuberculous mycobacteria
|
|
Miss Sumaya Mohayideen
Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana
Lower HbA1c and Increased Monocyte Activation in BCG-Vaccinated Type 1 Diabetes Patients in Ghana
|
|
Dr Alexandra Morrison
UK Health Security Agency, UK
Could new tuberculosis vaccines increase the risk of HIV transmission? Investigations using intravenously delivered BCG vaccine and rectal/vaginal swabs and biopsies in macaques
|
|
Dr Zaynab Mousavian
Karolinska Institute, Sweden
Plasma Protein Signatures for Active TB Diagnosis: 6-Marker and 4-Marker Panels as Promising Clinical Candidates
|
|
Miss Pamela Ncube
Stellenbosch University, South Africa
Genotypic and phenotypic assessment of Mycobacterium bovis persisters from wildlife specimens following in vitro stress
|
|
Miss Jomkwan Ongarj
University of Oxford, UK
Identification of humoral correlates of protection in a BCG controlled human infection model (CHIM)
|
|
Miss Tayla Smith
Africa Health Research Institute & University College London, South Africa & UK
Investigating M. tuberculosis ΔleuDΔpanCD as an in vitro persister model
|
|
Dr Andy Tran
City St George's, University of London, UK
Development of a Novel Self-adjuvanting Mucosal Vaccine for Tuberculosis (TB)
|
|
Dr Malek Trimèche
Institut Pasteur de Tunis, Tunisia
Effect of Phlebotomus papatasi Salivary Gland on the Development of Zoonotic Cutaneous Leishmaniasis in the Balb/c Mice Model
|
|
Dr Mohammad Uddin
icddr,b, Bangladesh
Innovating Extrapulmonary Tuberculosis Care with RISK6: Diagnosis and Treatment Monitoring
|
|
Dr Endalew Yizengaw
Bahir Dar University, Ethiopia
Neutrophil Effector Functions in Response to Different Isolates of Leishmania aethiopica
|
|
Ms Janet Zambezi
MRC The Gambia at LSHTM, The Gambia
The effect of N-acetyl cysteine on oxidative pathways leading to lung damage in Tuberculosis
|
